Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP629536.RACNC5bduk7zgNuDms2XzI21EUpUIFGNbfAFhLWgwGErY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP629536.RACNC5bduk7zgNuDms2XzI21EUpUIFGNbfAFhLWgwGErY130_assertion type Assertion NP629536.RACNC5bduk7zgNuDms2XzI21EUpUIFGNbfAFhLWgwGErY130_head.
- NP629536.RACNC5bduk7zgNuDms2XzI21EUpUIFGNbfAFhLWgwGErY130_assertion description "[In SSc fibroblasts, (1) the A2Ar is overexpressed and its occupancy with the selective agonist CGS-21680 increases collagen production, myofibroblast trans-differentiation, and ERK-1/2 phosphorylation; (2) the A2Ar forms an heteromer with the cannabinoid CB1 receptor; and (3) unselective cannabinoid receptor stimulation with a per se ineffective dose of WIN55,212-2, results in a marked anti-fibrotic effect after A2Ar blockage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP629536.RACNC5bduk7zgNuDms2XzI21EUpUIFGNbfAFhLWgwGErY130_provenance.
- NP629536.RACNC5bduk7zgNuDms2XzI21EUpUIFGNbfAFhLWgwGErY130_assertion evidence source_evidence_literature NP629536.RACNC5bduk7zgNuDms2XzI21EUpUIFGNbfAFhLWgwGErY130_provenance.
- NP629536.RACNC5bduk7zgNuDms2XzI21EUpUIFGNbfAFhLWgwGErY130_assertion SIO_000772 22033526 NP629536.RACNC5bduk7zgNuDms2XzI21EUpUIFGNbfAFhLWgwGErY130_provenance.
- NP629536.RACNC5bduk7zgNuDms2XzI21EUpUIFGNbfAFhLWgwGErY130_assertion wasDerivedFrom befree-20140225 NP629536.RACNC5bduk7zgNuDms2XzI21EUpUIFGNbfAFhLWgwGErY130_provenance.
- NP629536.RACNC5bduk7zgNuDms2XzI21EUpUIFGNbfAFhLWgwGErY130_assertion wasGeneratedBy ECO_0000203 NP629536.RACNC5bduk7zgNuDms2XzI21EUpUIFGNbfAFhLWgwGErY130_provenance.